These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15187212

  • 1. Imatinib mesylate treatment in two patients with idiopathic hypereosinophilic syndrome.
    Payne SM, Kovacs MJ.
    Ann Pharmacother; 2004; 38(7-8):1215-8. PubMed ID: 15187212
    [Abstract] [Full Text] [Related]

  • 2. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
    Garg A, Duggal L, Aggarwal S, Jain N.
    J Assoc Physicians India; 2006 Nov; 54():883-6. PubMed ID: 17249259
    [Abstract] [Full Text] [Related]

  • 3. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate.
    Schaller JL, Burkland GA.
    MedGenMed; 2001 Sep 07; 3(5):9. PubMed ID: 11698916
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate: a case report.
    Tan D, Hwang W, Ng HJ, Goh YT, Tan P.
    Int J Hematol; 2004 Jul 07; 80(1):75-7. PubMed ID: 15293573
    [Abstract] [Full Text] [Related]

  • 5. Effective treatment of hypereosinophilic syndrome with imatinib mesylate.
    Salem Z, Zalloua PA, Chehal A, Bitar N, Abboud M, Kadri A, Chami B, Bazarbachi A.
    Hematol J; 2003 Jul 07; 4(6):410-2. PubMed ID: 14671612
    [Abstract] [Full Text] [Related]

  • 6. Imatinib mesylate for the treatment of hypereosinophilic syndromes.
    Antoniu SA.
    Curr Opin Investig Drugs; 2006 Nov 07; 7(11):980-4. PubMed ID: 17117585
    [Abstract] [Full Text] [Related]

  • 7. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
    Moles MP, Landry J, Roche-Lestienne C, Godon A, Schmidt-Tanguy A, Gardembas M, Le Clech C, Verret JL, Zandecki M, Blanchet O.
    Ann Biol Clin (Paris); 2005 Nov 07; 63(3):317-22. PubMed ID: 15951264
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
    Hofmann SC, Technau K, Müller AM, Lübbert M, Bruckner-Tuderman L.
    J Am Acad Dermatol; 2007 May 07; 56(5 Suppl):S68-72. PubMed ID: 17097375
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases.
    Alcedo JC, Fábrega JM, Arosemena JR, Urrutia A.
    Head Neck; 2004 Sep 07; 26(9):829-31. PubMed ID: 15350030
    [Abstract] [Full Text] [Related]

  • 16. The hypereosinophilic syndromes: still more heterogeneity.
    Gleich GJ, Leiferman KM.
    Curr Opin Immunol; 2005 Dec 07; 17(6):679-84. PubMed ID: 16214314
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment with imatinib mesylate of hypereosinophilic syndrome (chronic eosinophilic leukemia) with myelofibrosis.
    Ishii Y, Ito Y, Kuriyama Y, Tauchi T, Ohyashiki K.
    Leuk Res; 2004 May 07; 28 Suppl 1():S79-80. PubMed ID: 15036947
    [No Abstract] [Full Text] [Related]

  • 18. Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase.
    Warren E, Ward S, Gordois A, Scuffham P.
    Clin Ther; 2004 Nov 07; 26(11):1924-33. PubMed ID: 15639704
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis.
    Musto P, Falcone A, Sanpaolo G, Bodenizza C, Perla G, Minervini MM, Cascavilla N, Dell'Olio M, La Sala A, Mantuano S, Melillo L, Nobile M, Scalzulli PR, Bisceglia M, Carella AM.
    Leuk Lymphoma; 2004 Jun 07; 45(6):1219-22. PubMed ID: 15360005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.